Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
D000962:Antimalarials / Q000633:toxicity*; D004358:Drug Therapy / Q000150:complications*; D004912:Erythrocytes / Q000494:pharmacology*; D006454:Hemoglobins / Q000737:chemistry*; D006461:Hemolysis / Q000209:etiology*; D008659:Metabolic Diseases; D010088:Oxidoreductases / Q000172:deficiency*; D011319:Primaquine
D000962:Antimalarials; D006454:Hemoglobins; D010088:Oxidoreductases; D011319:Primaquine
ANTIMALARIALS/toxicology; DEHYDROGENASES/deficiency; DRUG THERAPY/complications; ERYTHROCYTES/pharmacology; HEMOGLOBIN/chemistry; HEMOLYSIS/etiology